Immunomedics (IMMU) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	8.46M
Accounts receivable, net of allowance for doubtful accounts of $30,000 at September 30, 2011 and $32,000 at June 30, 2011	584.41K
Inventory	329.39K
Other receivables	0
Prepaid expenses	1.79M
Other current assets	358.37K
Total current assets	36.1M
Property and equipment, net of accumulated depreciation of $24,578,000 and $24,211,000 at September 30, 2011 and June 30, 2011, respectively	4.48M
Value of life insurance policies
Other long-term assets	30K
Total Assets	40.61M
Accounts payable and accrued expenses	14.12M
Total current liabilities	14.33M
Other liabilities	1.72M
Commitments and Contingencies	0
Preferred stock, $0.01 par value; authorized 10,000,000 shares; no shares issued and outstanding at September 30, 2011 and June 30, 2011	0
Common stock, $0.01 par value; authorized 110,000,000 shares; issued and outstanding, 75,477,735 shares at September 30, 2011 and 75,463,066 shares at June 30, 2011	959.78K
Capital contributed in excess of par
Treasury stock, at cost, 34,725 shares at September 30, 2011 and at June 30, 2011	-458.37K
Accumulated deficit	-384.7M
Accumulated other comprehensive income	-127.73K
Total Immunomedics, Inc. stockholders' equity	-72.24M
Noncontrolling interest in subsidiary	-741.79K
Total stockholders' equity	-72.98M
Total Liabilities and Stockholders' Equity	40.61M

Entities mentioned with IMMU

View All Entities